These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11787867)

  • 1. Immunological status of thalassemia syndrome.
    Ezer U; Gülderen F; Culha VK; Akgül N; Gürbüz O
    Pediatr Hematol Oncol; 2002; 19(1):51-8. PubMed ID: 11787867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characterization of circulating CD4/CD8 T-lymphocytes in β-thalassemia patients.
    Noulsri E; Lerdwana S; Fucharoen S; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):261-9. PubMed ID: 25268345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between cellular immune function during conditioning and graft rejection in patients with beta-thalassemia major].
    Hao WG; Huang SL; Sun X; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1375-7. PubMed ID: 19620057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
    Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
    Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Treg cells and FoxP3 expression in immunity of β-thalassemia major AND β-thalassemia trait patients.
    Bozdogan G; Erdem E; Demirel GY; Yildirmak Y
    Pediatr Hematol Oncol; 2010 Oct; 27(7):534-45. PubMed ID: 20677925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox.
    Aleem A; Shakoor Z; Alsaleh K; Algahtani F; Iqbal Z; Al-Momen A
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):467-71. PubMed ID: 25052967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection.
    Al-Ofairi BA; Barakat AB; Ghanim Hel-D; Shehata IH; El-Sayed MH
    Egypt J Immunol; 2011; 18(1):61-76. PubMed ID: 23082481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of thalassemia major patients in Indonesia with and without splenectomy.
    Sari TT; Gatot D; Akib AA; Bardosono S; Hadinegoro SR; Harahap AR; Idjradinata PS
    Acta Med Indones; 2014 Jul; 46(3):217-25. PubMed ID: 25348184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
    Gharagozloo M; Karimi M; Amirghofran Z
    Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell functions in infants and children with beta-thalassemia.
    Khalifa AS; Maged Z; Khalil R; Sabri F; Hassan O; el-Alfy M
    Acta Haematol; 1988; 79(3):153-6. PubMed ID: 3128038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status of Greek patients with beta-thalassemia major negative for anti-HIV.
    Choremi H; Sidiri E; Psarra K; Economidou J; Georgiopoulou P; Politi C; Roumeliotou A; Papaevangelou G
    Blut; 1987 May; 54(5):267-73. PubMed ID: 3105626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of circulating CD4
    Zahran AM; Saad K; Elsayh KI; Alblihed MA
    Int J Hematol; 2017 Mar; 105(3):265-271. PubMed ID: 27848181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
    Hagag AA; Elgamasy MA; Abd Elbar ES
    Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls.
    Spacek J; Vocka M; Netikova I; Skalova H; Dundr P; Konopasek B; Zavadova E; Lubos P
    Immunol Invest; 2018 Oct; 47(7):643-653. PubMed ID: 29924680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
    Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
    Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
    Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature senescence of T lymphocytes from patients with beta-thalassemia major.
    Gharagozloo M; Bagherpour B; Tahanian M; Oreizy F; Amirghofran Z; Sadeghi HM; Hourfar H; Moayedi B
    Immunol Lett; 2009 Jan; 122(1):84-8. PubMed ID: 19118576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity and T subpopulations in thalassemia major.
    Neri A; Brugiatelli M; Iacopino P; Callea V; Ronco F
    Acta Haematol; 1984; 71(4):263-9. PubMed ID: 6232810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered T and B lymphocytes in multitransfused patients of thalassemia major.
    Dua D; Choudhury M; Prakash K
    Indian Pediatr; 1993 Jul; 30(7):893-6. PubMed ID: 8132281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.